ArticleFrontiers in oncology2024

Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy.

José Luis Piñana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.